A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection

BACKGROUND: The primary objective of this meta-analytic study was to determine the impact of RSV-IGIV and palivizumab on risk of respiratory syncytial virus (RSV)-related hospitalization. Secondary objectives were to determine if antibody therapy decreases the risk of RSV infection, intensive care a...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, Shaun K, Dzolganovski, Biljana, Beyene, Joseph, Sung, Lillian
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720977/
https://www.ncbi.nlm.nih.gov/pubmed/19575815
http://dx.doi.org/10.1186/1471-2334-9-106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720977/
https://www.ncbi.nlm.nih.gov/pubmed/19575815
http://dx.doi.org/10.1186/1471-2334-9-106

Ejemplares similares